Takamitsu Hattori, PhD

Postdoctoral Researcher
Perlmutter Cancer Center, NYU Langone Health, United States

Disclosure information not submitted.

Presentation(s):

• CD97 (ADGRE5) – A Targetable Vulnerability in Glioblastoma

  Sunday, May 5, 2024
  1:43 PM – 1:45 PM CT